Bieżący numer
Archiwum
Artykuły zaakceptowane
O czasopiśmie
Rada naukowa
Bazy indeksacyjne
Kontakt
Zasady publikacji prac
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
2/2024
vol. 99 Artykuł przeglądowy
Hearing impairment in children – otolaryngologist’s perspective, causes, diagnosis, rehabilitation and hearing prosthetics
Kamila Bała
1
,
Karolina Dorobisz
1
Pediatr Pol 2024; 99 (2): 136-142
Data publikacji online: 2024/06/27
Plik artykułu:
- Hearing impairment.pdf
[0.32 MB]
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
INTRODUCTIONHearing, as one of the senses, is a vital element in every individual’s functioning. Its proper operation is necessary for a child to achieve developmental milestones at the right time. Hearing impairment represents a significant problem among children. Worldwide, it affects approximately 0.2% of newborns, 0.4% of infants, 1% of children aged 1–4, 1.5% of those aged 5–9, 1.7% of those aged 10–14, and 1.9% of those aged 15–19 [1]. Early hearing prosthetics using hearing aids or cochlear implants are crucial for children with sensorineural hearing loss [2]. Cochlear implants are among the most significant achievements in medicine and technology [3]. In Poland, the program for treating total deafness and profound hearing loss with cochlear implants began in 1992 [4]. A significant milestone in Polish oto-surgery was on 16th July 1992, when Professor Henryk Skarżyński performed the first cochlear implantation in Poland [3]. Since then, more than 12,500 cochlear implants have been implanted at the Institute of Physiology and Pathology of Hearing [5]. Approximately 800 patients undergo cochlear implantation annually across the country [6]. This paper aims to discuss the issue of hearing impairment and the possibilities of treatment through cochlear implantation.HEARING DIAGNOSISThe Universal Newborn Hearing Screening Program (UNHSP) in Poland has significantly contributed to early detection of hearing-impaired children. Poland was the first of the 9 countries in the world that conduct universal hearing screening covering over 90% of the population [7]. Before the establishment of the program, hearing screening was only conducted on newborns from the risk group for hearing impairment, and studies showed that the presence of hearing loss risk factors was observed in half of the cases [8]. Moreover, 90% of persistent sensorineural hearing impairments in children aged 0–5 are either congenital or acquired during the perinatal period [8]. These data indicated that newborn hearing screening should encompass the entire newborn population and be performed immediately after birth in the neonatal unit. Currently, within the first 3 days of a child’s life in the neonatal ward, a screening test using otoacoustic emissions (OAE) is performed. In the case of a normal result and no risk factors, the patient receives a blue certificate, as presented in Figure 1, which is included in the child’s health booklet. Children with abnormal OAE results, risk factors for hearing loss as presented in Table 1, or no OAE screening are issued a yellow certificate, also shown in Figure 1. Children with a yellow certificate are referred for retesting with OAE, followed by auditory brainstem response (ABR) testing for a precise objective assessment of hearing. Based on audiological examinations, patients qualify for hearing prosthetics using hearing aids. If conventional hearing aids do not yield the desired results according to the assessment criteria, cochlear implantation is proposed to the patient and their parents.According to the UNHSP report for the year 2022, 266 870 (96%) live-born children in Poland were covered by the program [9]. Parents of 22 194 children (8.32%) received a yellow certificate along with program leaflets and referrals to the second level of the UNHSP. Data from levels II and III in 2022 show that diagnostic evaluations were completed for 8 762 children (39.5%), and 177 were confirmed to have hearing impairment [9]. In 2021, 43% of children participated in the second level of the program, where abnormal hearing was diagnosed in 343 patients [10]. The data suggest a declining trend in child participation in subsequent hearing diagnostic stages. The most common type of hearing impairment in children examined at level II is bilateral sensorineural hearing loss, which, if undetected at an early developmental stage, can hinder proper child development. With moderate hearing impairment, speech development is delayed, and profound hearing loss results in no speech development. Speech is a primary means of communication, and its disruption lowers the patient’s and their family’s quality of life [11]. Additionally, a summary of 12 years of hearing screening programs among first and sixth-grade students attending primary schools in Warsaw showed that abnormal hearing test results were obtained for 25,559 children (13.3%). This demonstrates that hearing impairment is also a concern for an older age group, with primarily inflammatory causes—chronic inflammation of the nasal mucosa leading to Eustachian tube obstruction and subsequent chronic effusive otitis media [12]. The following audiological examinations are used for hearing diagnosis: subjective: pure-tone audiometry (from age 3), speech audiometry (from age 6–7), behavioral audiometry (under age 3), and objective tests, including ABR, OAE, and impedance audiometry. Failure to undertake diagnostic and therapeutic measures in these cases leads to learning difficulties, emotional disturbances, interpersonal problems, and delays in socio-cultural development [12]. IMPLANT PROGRAMA cochlear implant is an electronic device surgically implanted in the inner ear to transmit and process sounds into electrical signals, which are then directly conveyed to the auditory nerve. Treating patients with a cochlear implant involves a team of specialists working in the centers presented in Figure 2. The pediatric team responsible for the assessment for cochlear implantation, surgery, and rehabilitation comprises otolaryngology surgeons, pediatric anesthesiologists, audiologists, psychologists, speech therapists, clinical engineers and deaf educators [14]. Together, they make decisions regarding the eligibility or ineligibility of patients for cochlear implantation based on the indications for implantation and the latest scientific research in this field. The primary indications for cochlear implantation include bilateral deafness, bilateral residual hearing, bilateral profound sensorineural hearing loss and a lack of speech development despite appropriately fitted hearing aids and intensive rehabilitation for a minimum of 3–6 months [15]. Extended indications encompass bilateral cochlear implantations and implantations in cases of unilateral deafness [15]. Another crucial criterion is the absence of medical and radiological contraindications to cochlear implantation [16]. To determine this, a high-resolution computed tomography scan of the temporal bones and/or magnetic resonance imaging of the head is performed before the planned surgery. These tests allow for the early detection of congenital inner ear abnormalities (e.g., absence of the auditory nerve) as well as obliteration of fluid spaces in the vestibular system, often caused by ossification of the cochlea during meningitis [17]. Such abnormalities serve as contraindications to cochlear implantation, and in cases of hearing loss following meningitis, urgent implantation is necessary due to developing complications [16, 17]. Criteria for cochlear implant eligibility also take into account the child’s or parents’ sufficiently high motivation to cooperate and appropriate expectations regarding treatment outcomes [16]. The assessment committee makes the final decision based on previous examinations and observations. After being found eligible for cochlear implant surgery, the patient undergoes preparation so that implantation can occur before the child reaches 12 months of age [18]. Studies on the auditory system in young children have shown that cochlear implantation before the first year of life enables patients to acquire auditory and verbal skills during the period of greatest plasticity in the central nervous system [18]. Before a patient embarks on the diagnostic-therapeutic-rehabilitative path of cochlear implant qualification presented in Table 2, they must be referred by a physician whose knowledge of the indications can aid in their daily clinical practice.ELIGIBILITY CRITERIA LIMITATIONSBased on evidence-based practice, it is emphasized that cochlear implantation in children should be performed as early as possible to facilitate their language development [20]. Studies suggest that early implantation can prevent long-term speech language deficits in children [21]. A 10-year observation of two groups of children who received implants before or after 12 months of age showed that after 5 years, all younger children who received implants at an earlier age had speech understandable to an average listener, compared to 67% of children who received implants later [22]. Additionally, this study found significantly better results in the grammatical development of the younger group [22]. In children with single-sided deafness, where the goal is to provide bilateral stimulation for the development of binaural hearing, a meta-analysis showed that cochlear implantation improved speech perception in noise and quiet, as well as sound localization [23, 24]. Furthermore, the average age at implantation in individuals not using implants was statistically significantly higher than the age at implantation in those using implants regularly or intermittently [24]. In addition to the benefits for the patient, the decision for early implantation is influenced by safety studies. In a study involving 136 patients aged 3.6–11.9 months, patients were divided into those under 9 months and those 9–11 months old [25]. There were no significant differences in the frequency or severity of adverse events between the two groups at the time of surgery [25]. To emphasize the importance of early fitting of a hearing aid, which has a wearing period of 3–6 months before cochlear implantation, the current guidelines of the Joint Committee on Infant Hearing state that hearing screening should be conducted by 1 month of age, hearing loss or deafness identification should occur by 3 months of age, and therapeutic intervention by 6 months of age [26].COLLABORATION AMONG PEDIATRICIANS, FAMILY DOCTORS, SPEECH THERAPISTS, NEUROLOGISTS, PSYCHIATRISTS, AND OTOLARYNGOLOGISTSHearing loss is an interdisciplinary problem. In a study conducted in Israel involving children aged 2–12 years referred for hearing assessment for various reasons, it was found that if a child was referred to a doctor due to suspected hearing loss, the likelihood of an abnormal audiometric result was 54% [27]. Parents, doctors, speech therapists and teachers were among those who raised concerns about hearing loss [27]. Pediatricians and family doctors have direct contact with children and their parents during vaccinations, conservative treatment or periodic developmental assessments [28]. They should verify parents’ observations about a child’s hearing impairment, delayed speech development and speech defects. Chronic otitis media with effusion is a common cause of conductive hearing loss. In this case, parents of older children may report that the child understands speech well over the phone, hears better in noise than in silence, and that increasing the volume of the television or radio improves their understanding of speech [29]. The most common causes of sensorineural hearing loss are genetic and acquired factors [30]. In the interview, parents may report that the child can hear but not understand, that there has been a decline in speech comprehension in noise, and an unpleasant sensation of very loud sounds in the ear with hearing loss [29]. During the visit, attention should be paid to the yellow certificate in the child’s health booklet, as the presence of risk factors for hearing loss (Table 1) in a child may lead to delayed-onset hearing loss [31]. Therefore, if the child is not yet under the care of level II and III reference centers of the UNHSP, they should be referred as soon as possible to complete audiological diagnostics. Before referring a patient to a speech therapist for delayed speech development and speech defects, hearing diagnostics should be carried out in a laryngological outpatient clinic. In some cases, children should also be evaluated by a psychologist, neurologist, and sometimes a child psychiatrist. In searching for the causes of this disorder, hearing loss, intellectual disability or autism spectrum disorders should be taken into account [32]. After excluding hearing loss, the child can start intensive speech therapy [32].PARENTS’ PERSPECTIVEEffective collaboration with the parents of a patient is a crucial element in the process of cochlear implant candidacy assessment, as well as treatment and rehabilitation. It is important to understand the parents’ expectations, their education, involvement, and logistical possibilities related to the family’s place of residence. A study assessed parents’ expectations regarding communication, speech hearing, and speech development of their children based on a survey before implantation and 1, 2, and 3 years after implantation [33]. The results indicated that preoperative expectations were met or exceeded in each time frame in a given category [33]. Parents’ satisfaction with cochlear implants is also influenced by factors related to their place of residence. Studies in Poland have shown that as many as 74% of respondents live more than 100 km away from the implantation center, and 52% of families need more than 3 hours to reach the implantation center [34]. Consequently, 56% of respondents express a willingness to use the services of a center located closer to their place of residence [34]. One solution to this problem is remote fitting and adaptation of the speech processor, also known as ‘telefitting’. It involves specialists from implanting facilities using the Internet to organize a teleconference, enabling both audio and visual communication with the patient and supporting staff in collaborating clinics across the country [35]. Additionally, remote desktop software makes it possible to take control of a distant computer, facilitating measurements and adjustments to the speech processor [35]. A study involving 20 cochlear implant users who underwent remote fitting showed that 90% of the respondents found this procedure not difficult; for most, the audio and video quality was good, and 85% of the individuals wanted to use online fitting again [36]. This solution saves time and reduces the costs associated with travel and work absence, and children do not have to miss school. The awareness of the consequences of early implantation in a child is influenced by the education of the parents, especially the child’s mother. Research in California indicated that an increase of 1 percentage point in the number of mothers who had completed high school was correlated with a 5 percentage point increase in the number of children aged 2 and younger receiving implants [37]. It is worth noting that among the reasons for not using cochlear implants in children, the lack of adequate family support was mentioned [24].CONCLUSIONSThe implant program, including patient assessment, treatment, and rehabilitation, is a complex and lengthy process that offers children with bilateral deafness a chance for proper speech development. In the observed situation of insufficient coverage of high-risk children with hearing screening, knowledge of its principles enables physicians to educate parents. It is also important to understand and appreciate the family factors that influence the course of implantation. The efforts of specialists can influence parents’ decisions to seek treatment, providing children with a chance for proper speech development in the future.Disclosures
REFERENCES1. The importance of hearing across the life course – decline in hearing capacity. World report on hearing. Geneva: World Health Organization 2021, 36-43. 2.
Kocoń S, Wiatr A, Stręk P, et al. Analysis of diagnostic-therapeutic results after the first year of life in children of hearing disturbance risk groups. Otolaryngol Pol 2018; 72: 11-18. 3.
Lorens A, Skarżyński H. Technologia implantów ślimakowych. Now Audiofonol 2012; 1: 18-23. 4.
Piotrowska A, Lorens A, Obrycka A, et al. Implanty ślimakowe – wczoraj i dziś. Now Audiofonol 2014; 3: 23-27. 5.
O instytucie. Instytut Fizjologii i Patologii Słuchu. Available from: https://whc.ifps.org.pl/o-nas/o-instytucie/. 6.
Bieńkowska KI, Mierzwiński J, Gawłowska MB, et al. Report on the international Euro-CIU symposium on implant users in Wrocław – the needs of hearing implant users in the modern world’. Pol Otorhino Rev 2019; 8: 59-60. 7.
Wróbel M, Szyfter W. Program Powszechnych Przesiewowych Badań Słuchu u Noworodków w Polsce. Post Chir Głowy Szyi 2011; 2: 56-59. 8.
Radziszewska-Konopka M. Program Powszechnych Przesiewowych Badań Słuchu u Noworodków w Polsce organizowany przez Fundację Wielkiej Orkiestry Świątecznej Pomocy. Audiofonologia 2002; 21: 107-119. 9.
Greczka G. Raport za 2022 rok PPPBSuN, dane z dnia 07.12.2022 r. Uszko 2023; 23: 10-15. 10.
Greczka G, Zych M, Dąbrowski P, et al. Summary of the Polish Universal Neonatal Hearing Screening Program – 2021 year review. Otolaryngol Pol 2023; 77: 1-4. 11.
Czerniejewska-Wolska H, Kałos M, Gawłowska MB, et al. Evaluation of quality of life in patients after cochlear implantation surgery in 2014–2017. Otolaryngol Pol 2019; 73: 11-17. 12.
Skarżyński PH, Skarżyński H, Świerniak W, et al. Podsumowanie 12 lat realizacji programów badań przesiewowych słuchu wśród uczniów klas I i VI uczęszczających do szkół podstawowych w Warszawie. Now Audiofonol 2023; 12: 55-62. 13.
The Joint Committee on Infant Hearing, Year 2019 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs. J Early Hearing Detect Intervention 2019; 4: 1-44. 14.
Skarżyński H, Mielnik-Niedzielska G, Kochanek K, et al. Standardy jakości stosowania implantów ślimakowych u niemowląt, dzieci i młodzieży. Stanowisko Towarzystwa Otorynolaryngologów, Foniatrów i Audiologów Polskich oraz Polskiego Towarzystwa Oto- laryngologów Dziecięcych. Now Audiofonol 2018; 7: 7-15. 15.
Karlik M, Wiskirska-Woźnica BSekula A. Remarks on qualification of patients for cochlear implantation. Pol Otorhino Rev 2016; 5: 18-21. 16.
Mierzwinski J, Wrukowska-Niemczewska I, Lewandowski A, et al. Current indications for the treatment of deafness with the use of cochlear and brainstem implants in children. New directions and possibilities. Pol Otorhino Rev 2021; 10: 6-17. 17.
Haber K, Burzynska-Makuch M, Mierzwinski J. The role of preoperative imaging for auditory implants in children. Otolaryngol Pol 2020; 74: 1-13. 18.
Geremek-Samsonowicz A, Katarzyna Kłonica L, Rostkowska J, et al. Model postępowania diagnostyczno-terapeutycznego wobec niemowlęcia i jego rodziny przed operacją wszczepienia implantu ślimakowego. Now Audiofonol 2012; 1: 119-125. 19.
Przewoźny T, Kuczkowski J, Molisz A, et al. Nowoczesne zasady kwalifikacji chorych do implantacji ślimakowych. Forum Med Rodz 2013; 7: 342-348. 20.
Park LR, Gagnon EB, Brown KD. The limitations of FDA criteria: inconsistencies with clinical practice, findings, and adult criteria as a barrier to pediatric implantation. Semin Hear 2021; 42: 373-380. 21.
Purcell PL, Deep NL, Waltzman SB, et al. Cochlear implantation in infants: why and how. Trends Hear 2021; 25: 1-10. 22.
Colletti L, Mandalà M, Zoccante L, et al. Infants versus older children fitted with cochlear implants: performance over 10 years. Int J Pediatr Otorhinolaryngol 2011; 75: 504-509. 23.
Park LR, Griffin AM, Sladen DP, et al. American cochlear implant alliance task force guidelines for clinical assessment and management of cochlear implantation in children with single-sided deafness. Ear Hear 2022; 43: 255-267. 24.
Benchetrit L, Ronner EA, Anne S, et al. Cochlear implantation in children with single-sided deafness: a systematic review and meta- analysis. JAMA Otolaryngol Head Neck Surg 2021; 147: 58-69. 25.
Deep NL, Purcell PL, Gordon KA, et al. Cochlear implantation in infants: evidence of safety. Trends Hear 2021; 25: 1-11. 26.
Warner-Czyz AD, Roland JT Jr, Thomas D, Uhler K, Zombek L. American cochlear implant alliance task force guidelines for determining cochlear implant candidacy in children. Ear Hear 2022; 43: 268-282. 27.
Slovik Y, Gorali R, Dizitzer Y, et al. Predicting hearing loss in children according to the referrer and referral cause. Int J Pediatr Otorhinolaryngol 2020; 128: 1-22. 28.
Polski B, Szydłowski J, Pucher B, et al. The GP’s role in the early detection of hearing loss process, realized by the Universal Neonatal Hearing Screenings of Infants Program. Family Med Primary Care Rev 2014; 16: 148-149. 29.
Janczewski G. Otolaryngologia praktyczna. Podręcznik dla studentów i lekarzy, tom I. Via Medica, Gdańsk 2005, 8-11. 30.
Van Beeck Calkoen EA, Engel MSD, van de Kamp JM, et al. The etiological evaluation of sensorineural hearing loss in children. Eur J Pediatr 2019; 178: 1195-1205. 31.
Lieu JEC, Kenna M, Anne S, Davidson L. Hearing loss in children: a review. JAMA 2020; 324: 2195-2205. 32.
Nouraey P, Ayatollahi MA, Moghadas M. Late language emergence: a literature review. Sultan Qaboos Univ Med J 2021; 21: e182-e190. 33.
Nikolopoulos TP, Lloyd H, Archbold S, et al. Pediatric cochlear implantation: the parents’ perspective. Arch Otolaryngol Head Neck Surg 2001; 127: 363-367. 34.
Gawlowska M, Wierzbicka M, Kida M, et al. The survey of parents’ and adults recipients’ satisfaction with cochlear implantation determined by the place of residence. Otolaryngol Pol 2020; 74: 21-28. 35.
Wąsowski A, Skarżyński H, Bruski Ł, et al. Metoda zdalnego dopasowania implantu (telefitting) w Ogólnopolskiej Sieci Teleau- diologii. Now Audiofonol 2012; 1: 39-43. 36.
Takano K, Kaizaki A, Kimura A, et al. Telefitting of nucleus cochlear implants: a feasibility study. Am J Audiol 2021; 30: 16-21. 37.
Fujiwara RJT, Ishiyama G, Ishiyama A. Association of socioeconomic characteristics with receipt of pediatric cochlear implantations in California. JAMA Netw Open 2022; 5: 1-11.
Copyright: © 2024 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|